Bicycle Therapeutics Cash from Financing (Quarterly) Insights

Bicycle Therapeutics PLC (BCYC)

20.54 +0.28 (+1.38%) USD | NASDAQ | Nov 22, 16:00

20.57 +0.03 (+0.15%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	-31.93M
June 30, 2024	549.61M
March 31, 2024	1.871M
December 31, 2023	0.386M
September 30, 2023	234.63M
June 30, 2023	12.29M
March 31, 2023	2.718M
December 31, 2022	5.888M
September 30, 2022	0.159M
June 30, 2022	0.195M
March 31, 2022	0.45M
December 31, 2021	190.66M
September 30, 2021	40.45M
June 30, 2021	15.55M

Date	Value
March 31, 2021	74.06M
December 31, 2020	1.744M
September 30, 2020	61.09M
June 30, 2020	0.01M
March 31, 2020	0.002M
December 31, 2019	0.122M
September 30, 2019	-0.811M
June 30, 2019	59.10M
March 31, 2019	0.034M
December 31, 2018	25.43M
September 30, 2018	0.001M
June 30, 2018	0.00
March 31, 2018	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-31.93M

Minimum

Sep 2024

549.61M

Maximum

Jun 2024

58.00M

Average

2.294M

Median

Cash from Financing (Quarterly) Benchmarks

TC BioPharm (Holdings) PLC	1.183M
Adaptimmune Therapeutics PLC	25.00M
NuCana PLC	-0.0888M
Autolus Therapeutics PLC	0.185M
Biodexa Pharmaceuticals PLC	--

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-39.83M
Cash from Investing (Quarterly)	-0.435M
Free Cash Flow	-203.53M
Free Cash Flow Per Share (Quarterly)	-0.5837
Free Cash Flow to Equity (Quarterly)	-9.358M
Free Cash Flow to Firm (Quarterly)	-40.27M
Free Cash Flow Yield	-19.24%